Cargando…

Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study

BACKGROUND: The role of the complement system in the pathogenesis of systemic sclerosis (SSc) is controversial. This study investigated the role of the lectin pathway of complement as a mediator of ischemia/reperfusion injury in SSc. METHODS: This is a prospective observational cross-sectional study...

Descripción completa

Detalles Bibliográficos
Autores principales: Osthoff, Michael, Jaeger, Veronika K., Heijnen, Ingmar A. F. M., Trendelenburg, Marten, Jordan, Suzana, Distler, Oliver, Walker, Ulrich A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423822/
https://www.ncbi.nlm.nih.gov/pubmed/30885245
http://dx.doi.org/10.1186/s13075-019-1859-1
_version_ 1783404594179604480
author Osthoff, Michael
Jaeger, Veronika K.
Heijnen, Ingmar A. F. M.
Trendelenburg, Marten
Jordan, Suzana
Distler, Oliver
Walker, Ulrich A.
author_facet Osthoff, Michael
Jaeger, Veronika K.
Heijnen, Ingmar A. F. M.
Trendelenburg, Marten
Jordan, Suzana
Distler, Oliver
Walker, Ulrich A.
author_sort Osthoff, Michael
collection PubMed
description BACKGROUND: The role of the complement system in the pathogenesis of systemic sclerosis (SSc) is controversial. This study investigated the role of the lectin pathway of complement as a mediator of ischemia/reperfusion injury in SSc. METHODS: This is a prospective observational cross-sectional study of 211 SSc patients and 29 patients with Raynaud’s phenomenon in undifferentiated connective tissue disease (UCTD) at risk of developing SSc from two outpatient clinics. Serum levels of lectin pathway proteins (FCN-2, FCN-3, MBL, and MASP-2) and eight MBL2 and FCN2 single-nucleotide polymorphisms (SNP) were analyzed by sandwich-type immunoassays and genotyping and examined for their association with disease manifestations. RESULTS: Lectin pathway protein levels and SNPs were similar between SSc and UCTD patients. FCN-2 levels were however higher in SSc patients with present evidence of digital ulcers (mean 1.4 vs. 1.0 μg/mL, p = 0.05), pitting scars (mean 1.3 vs. 1.0 μg/mL, p = 0.01), and puffy fingers (mean 1.2 vs. 1.0 μg/mL, p = 0.04). Similarly, higher FCN-2 levels were observed in SSc patients with Scl-70 autoantibodies (mean 1.5 vs. 1.0 μg/mL, p = 0.001), interstitial lung disease (mean 1.2 vs. 0.9 μg/mL, p = 0.02), and a forced vital capacity (FVC) below 80% (mean 1.4 vs. 1.0 μg/mL, p = 0.02). In line, variant alleles in the FCN-2 SNP at position + 6359 were associated with a significantly reduced FVC and diffusion capacity. Furthermore, patients with SSc renal crisis harbored higher MBL levels (mean 2.7 vs. 1.5 μg/mL, p = 0.04). No other lectin pathway protein levels or polymorphisms were associated with disease manifestations, low complement C3 and/or C4 levels, or inflammatory markers. CONCLUSIONS: This study does not support a relevant role for several lectin pathway complement proteins in the pathogenesis of SSc. Higher FCN-2 levels were however associated with Scl-70 autoantibody positivity, interstitial lung involvement, and digital vasculopathy. Elevated MBL levels were associated with renal crisis.
format Online
Article
Text
id pubmed-6423822
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64238222019-03-28 Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study Osthoff, Michael Jaeger, Veronika K. Heijnen, Ingmar A. F. M. Trendelenburg, Marten Jordan, Suzana Distler, Oliver Walker, Ulrich A. Arthritis Res Ther Research Article BACKGROUND: The role of the complement system in the pathogenesis of systemic sclerosis (SSc) is controversial. This study investigated the role of the lectin pathway of complement as a mediator of ischemia/reperfusion injury in SSc. METHODS: This is a prospective observational cross-sectional study of 211 SSc patients and 29 patients with Raynaud’s phenomenon in undifferentiated connective tissue disease (UCTD) at risk of developing SSc from two outpatient clinics. Serum levels of lectin pathway proteins (FCN-2, FCN-3, MBL, and MASP-2) and eight MBL2 and FCN2 single-nucleotide polymorphisms (SNP) were analyzed by sandwich-type immunoassays and genotyping and examined for their association with disease manifestations. RESULTS: Lectin pathway protein levels and SNPs were similar between SSc and UCTD patients. FCN-2 levels were however higher in SSc patients with present evidence of digital ulcers (mean 1.4 vs. 1.0 μg/mL, p = 0.05), pitting scars (mean 1.3 vs. 1.0 μg/mL, p = 0.01), and puffy fingers (mean 1.2 vs. 1.0 μg/mL, p = 0.04). Similarly, higher FCN-2 levels were observed in SSc patients with Scl-70 autoantibodies (mean 1.5 vs. 1.0 μg/mL, p = 0.001), interstitial lung disease (mean 1.2 vs. 0.9 μg/mL, p = 0.02), and a forced vital capacity (FVC) below 80% (mean 1.4 vs. 1.0 μg/mL, p = 0.02). In line, variant alleles in the FCN-2 SNP at position + 6359 were associated with a significantly reduced FVC and diffusion capacity. Furthermore, patients with SSc renal crisis harbored higher MBL levels (mean 2.7 vs. 1.5 μg/mL, p = 0.04). No other lectin pathway protein levels or polymorphisms were associated with disease manifestations, low complement C3 and/or C4 levels, or inflammatory markers. CONCLUSIONS: This study does not support a relevant role for several lectin pathway complement proteins in the pathogenesis of SSc. Higher FCN-2 levels were however associated with Scl-70 autoantibody positivity, interstitial lung involvement, and digital vasculopathy. Elevated MBL levels were associated with renal crisis. BioMed Central 2019-03-18 2019 /pmc/articles/PMC6423822/ /pubmed/30885245 http://dx.doi.org/10.1186/s13075-019-1859-1 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Osthoff, Michael
Jaeger, Veronika K.
Heijnen, Ingmar A. F. M.
Trendelenburg, Marten
Jordan, Suzana
Distler, Oliver
Walker, Ulrich A.
Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study
title Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study
title_full Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study
title_fullStr Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study
title_full_unstemmed Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study
title_short Role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study
title_sort role of lectin pathway complement proteins and genetic variants in organ damage and disease severity of systemic sclerosis: a cross-sectional study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423822/
https://www.ncbi.nlm.nih.gov/pubmed/30885245
http://dx.doi.org/10.1186/s13075-019-1859-1
work_keys_str_mv AT osthoffmichael roleoflectinpathwaycomplementproteinsandgeneticvariantsinorgandamageanddiseaseseverityofsystemicsclerosisacrosssectionalstudy
AT jaegerveronikak roleoflectinpathwaycomplementproteinsandgeneticvariantsinorgandamageanddiseaseseverityofsystemicsclerosisacrosssectionalstudy
AT heijneningmarafm roleoflectinpathwaycomplementproteinsandgeneticvariantsinorgandamageanddiseaseseverityofsystemicsclerosisacrosssectionalstudy
AT trendelenburgmarten roleoflectinpathwaycomplementproteinsandgeneticvariantsinorgandamageanddiseaseseverityofsystemicsclerosisacrosssectionalstudy
AT jordansuzana roleoflectinpathwaycomplementproteinsandgeneticvariantsinorgandamageanddiseaseseverityofsystemicsclerosisacrosssectionalstudy
AT distleroliver roleoflectinpathwaycomplementproteinsandgeneticvariantsinorgandamageanddiseaseseverityofsystemicsclerosisacrosssectionalstudy
AT walkerulricha roleoflectinpathwaycomplementproteinsandgeneticvariantsinorgandamageanddiseaseseverityofsystemicsclerosisacrosssectionalstudy